d information technology is enabling a period of innovation in healthcare that sets a uniquely positive environment for the investment of NLV-IIL. e More Favorable Regulatory Environment For New Drug Approvals: Increasing numbers of FDA drug approvals and recently passed U.S. regulatory legislation are reflective of a more favorable regulatory environment. The number o